Tema Heart & Health ETF (NASDAQ:HRTS – Get Free Report) shares rose 1% during trading on Wednesday . The company traded as high as $34.40 and last traded at $34.33. Approximately 14,098 shares were traded during trading, an increase of 69% from the average daily volume of 8,336 shares. The stock had previously closed at $33.99.
Tema Heart & Health ETF Trading Up 1.0%
The firm has a market capitalization of $53.21 million, a PE ratio of 22.06 and a beta of 0.97. The company has a fifty day moving average price of $31.71 and a two-hundred day moving average price of $29.58.
Hedge Funds Weigh In On Tema Heart & Health ETF
Institutional investors have recently modified their holdings of the business. JPMorgan Chase & Co. purchased a new position in Tema Heart & Health ETF during the 2nd quarter worth $63,000. Oliver Lagore Vanvalin Investment Group acquired a new position in shares of Tema Heart & Health ETF in the second quarter valued at approximately $905,000. Jane Street Group LLC increased its holdings in shares of Tema Heart & Health ETF by 9.4% in the second quarter. Jane Street Group LLC now owns 37,164 shares of the company’s stock valued at $1,062,000 after purchasing an additional 3,202 shares during the period. CoreCap Advisors LLC lifted its holdings in shares of Tema Heart & Health ETF by 25,280.4% during the third quarter. CoreCap Advisors LLC now owns 51,776 shares of the company’s stock worth $1,602,000 after purchasing an additional 51,572 shares during the period. Finally, Flow Traders U.S. LLC acquired a new stake in shares of Tema Heart & Health ETF during the first quarter worth $1,655,000.
Tema Heart & Health ETF Company Profile
The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.
Featured Articles
- Five stocks we like better than Tema Heart & Health ETF
- What is diluted earnings per share (Diluted EPS)?
- Rare Earth Stocks: The Truce That Isn’t a Truce
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Carving Up Profits: 3 Food Stocks on the Thanksgiving Table
- Comparing and Trading High PE Ratio Stocks
- C3.ai’s Reset: Why New Leadership Could Spark a Turnaround
Receive News & Ratings for Tema Heart & Health ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tema Heart & Health ETF and related companies with MarketBeat.com's FREE daily email newsletter.
